1-11786035-G-GT
Variant names:
Variant summary
Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP6_ModerateBA1
The NM_005957.5(MTHFR):c.*4644dupA variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.98 ( 72511 hom., cov: 0)
Failed GnomAD Quality Control
Consequence
MTHFR
NM_005957.5 3_prime_UTR
NM_005957.5 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.535
Genes affected
MTHFR (HGNC:7436): (methylenetetrahydrofolate reductase) The protein encoded by this gene catalyzes the conversion of 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate, a co-substrate for homocysteine remethylation to methionine. Genetic variation in this gene influences susceptibility to occlusive vascular disease, neural tube defects, colon cancer and acute leukemia, and mutations in this gene are associated with methylenetetrahydrofolate reductase deficiency.[provided by RefSeq, Oct 2009]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -10 ACMG points.
BP6
Variant 1-11786035-G-GT is Benign according to our data. Variant chr1-11786035-G-GT is described in ClinVar as [Benign]. Clinvar id is 292153.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.987 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MTHFR | NM_005957.5 | c.*4644dupA | 3_prime_UTR_variant | Exon 12 of 12 | ENST00000376590.9 | NP_005948.3 | ||
C1orf167 | NM_001010881.2 | c.3567+757dupT | intron_variant | Intron 16 of 20 | ENST00000688073.1 | NP_001010881.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MTHFR | ENST00000376590.9 | c.*4644dupA | 3_prime_UTR_variant | Exon 12 of 12 | 1 | NM_005957.5 | ENSP00000365775.3 | |||
C1orf167 | ENST00000688073.1 | c.3567+757dupT | intron_variant | Intron 16 of 20 | NM_001010881.2 | ENSP00000510540.1 |
Frequencies
GnomAD3 genomes AF: 0.984 AC: 147309AN: 149702Hom.: 72488 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
147309
AN:
149702
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome Data not reliable, filtered out with message: AC0AC: 0AN: 0Hom.: 0 Cov.: 0AC XY: 0AN XY: 0
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AC:
0
AN:
0
Hom.:
Cov.:
0
AC XY:
0
AN XY:
0
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AC:
0
AN:
0
Other (OTH)
AC:
0
AN:
0
GnomAD4 genome AF: 0.984 AC: 147373AN: 149790Hom.: 72511 Cov.: 0 AF XY: 0.983 AC XY: 71732AN XY: 72966 show subpopulations
GnomAD4 genome
AF:
AC:
147373
AN:
149790
Hom.:
Cov.:
0
AF XY:
AC XY:
71732
AN XY:
72966
show subpopulations
African (AFR)
AF:
AC:
39346
AN:
40922
American (AMR)
AF:
AC:
15011
AN:
15098
Ashkenazi Jewish (ASJ)
AF:
AC:
3433
AN:
3440
East Asian (EAS)
AF:
AC:
5128
AN:
5144
South Asian (SAS)
AF:
AC:
4722
AN:
4726
European-Finnish (FIN)
AF:
AC:
9568
AN:
9802
Middle Eastern (MID)
AF:
AC:
288
AN:
290
European-Non Finnish (NFE)
AF:
AC:
66939
AN:
67402
Other (OTH)
AF:
AC:
2034
AN:
2062
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.547
Heterozygous variant carriers
0
91
182
274
365
456
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Neural tube defects, folate-sensitive Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
Loading publications...